AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Publishing Language: Chinese | Open Access

Research progress on polydopamine in the treatment of oral diseases

Xiangxiang LU1Zhen JIANG2Aili XING1Bin ZHAO3Bin SUN1( )
Department of Oral and Maxillofacial Surgery (Third Division), Hospital of Stomatology, Jilin University, Changchun 130021, China
Department of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun 130021, China
Department of Periodontics, Hospital of Stomatology, Jilin University, Changchun 130021, China
Show Author Information

Abstract

Due to the moist environment in the mouth, there are many challenges that arise, such as difficult biofilm removal, short drug retention time, and low tissue repair efficiency, while treating dental caries, periodontal disease, and other oral diseases. As a biomimetic biomaterial, polydopamine (PDA) possesses multifunctional properties, including mussel-inspired adhesion and stimuli-responsive drug release. PDA adhesion properties originate from its surface catechol and amino functional groups, which maintain strong wettability in aqueous environments. With smart responsiveness encompassing photothermal, pH, and enzymatic stimuli, PDA enables controlled drug release under specific conditions. Additionally, PDA exhibits antibacterial, anti-inflammatory, and osteoblast-promoting functions, thus demonstrating significant application potential in the treatment of oral diseases. In hard tissue therapies, specifically for dental caries, PDA promotes enamel remineralization by inducing hydroxyapatite crystal growth and enhances dentin collagen mineralization through Ca2+ chelation while inhibiting cariogenic bacteria. In mandibular defect repair, functionalized PDA coatings on bone implants facilitate mesenchymal stem cell adhesion and differentiation, activate osteogenic signaling pathways, and synergistically promote vascularization to improve bone-implant integration. For soft tissue treatments, specifically for periodontitis, PDA alleviates alveolar bone resorption via antibacterial and anti-inflammatory effects coupled with osteoclast inhibition. In denture stomatitis management, PDA’s strong wet adhesion prolongs drug retention, while its photothermal effect and reactive oxygen generation provide both broad-spectrum antibacterial activity and wound healing promotion. This review summarizes PDA’s synthesis mechanisms and biological functions, with an emphasis on its therapeutic applications in oral diseases, providing innovative strategies for oral healthcare.

CLC number: R78 Document code: A Article ID: 2096-1456(2026)03-0302-13

References

【1】
【1】
 
 
Journal of Prevention and Treatment for Stomatological Diseases
Pages 302-314

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
LU X, JIANG Z, XING A, et al. Research progress on polydopamine in the treatment of oral diseases. Journal of Prevention and Treatment for Stomatological Diseases, 2026, 34(3): 302-314. https://doi.org/10.12016/j.issn.2096-1456.202550260

111

Views

0

Downloads

0

Crossref

0

Scopus

Received: 19 June 2025
Revised: 06 August 2025
Published: 20 March 2026
© 2026 by Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases